• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

适应性试验设计:我们能否采用这种方法来改进全球卫生领域的临床试验?

Adaptive trial design: could we use this approach to improve clinical trials in the field of global health?

机构信息

Global Health Clinical Trials Programme, Centre for Tropical Medicine, University of Oxford, Oxford, United Kingdom.

出版信息

Am J Trop Med Hyg. 2011 Dec;85(6):967-70. doi: 10.4269/ajtmh.2011.11-0151.

DOI:10.4269/ajtmh.2011.11-0151
PMID:22144428
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3225172/
Abstract

We need more clinical trials in the world's poorest regions to evaluate new drugs and vaccines, and also to find better ways to manage health issues. Clinical trials are expensive, time consuming, and cumbersome. However, in wealthier regions these limiting factors are being addressed to make trials less administrative and improve the designs. A good example is adaptive trial design. This innovation is becoming accepted by the regulators and has been taken up by the pharmaceutical industry to reduce product development times and costs. If this approach makes trials easier and less expensive surely we should be implementing this approach in the field of tropical medicine and international health? As yet this has rarely been proposed and there are few examples. There is a need for raising the awareness of these design approaches because they could be used to make dramatic improvements to clinical research in developing countries.

摘要

我们需要在世界上最贫穷的地区开展更多的临床试验,以评估新药和疫苗,并找到更好的方法来处理健康问题。临床试验既昂贵又耗时,而且程序繁琐。然而,在较富裕的地区,这些限制因素正在得到解决,以使试验的管理工作不那么繁重,并改进设计。一个很好的例子是适应性试验设计。这一创新正在被监管机构所接受,并已被制药行业所采用,以减少产品开发的时间和成本。如果这种方法使试验变得更容易、更便宜,那么我们当然应该在热带医学和国际卫生领域采用这种方法?然而,这一方法很少被提出,也几乎没有例子。我们需要提高对这些设计方法的认识,因为它们可以被用来显著改善发展中国家的临床研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c39d/3225172/ba083dd40958/tropmed-85-967-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c39d/3225172/ba083dd40958/tropmed-85-967-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c39d/3225172/ba083dd40958/tropmed-85-967-g001.jpg

相似文献

1
Adaptive trial design: could we use this approach to improve clinical trials in the field of global health?适应性试验设计:我们能否采用这种方法来改进全球卫生领域的临床试验?
Am J Trop Med Hyg. 2011 Dec;85(6):967-70. doi: 10.4269/ajtmh.2011.11-0151.
2
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
3
Overview, hurdles, and future work in adaptive designs: perspectives from a National Institutes of Health-funded workshop.适应性设计概述、障碍及未来工作:来自 NIH 资助研讨会的观点。
Clin Trials. 2012 Dec;9(6):671-80. doi: 10.1177/1740774512461859.
4
Tuberculosis结核病
5
The role of adaptive trial designs in drug development.适应性试验设计在药物研发中的作用。
Expert Rev Clin Pharmacol. 2017 Jul;10(7):727-736. doi: 10.1080/17512433.2017.1321985. Epub 2017 Apr 28.
6
Criteria for site selection in industry-sponsored clinical trials: a survey among decision-makers in biopharmaceutical companies and clinical research organizations.行业赞助的临床试验中的选址标准:对生物制药公司和临床研究组织的决策者进行的一项调查。
Trials. 2019 Dec 11;20(1):708. doi: 10.1186/s13063-019-3790-9.
7
Innovation in oncology clinical trial design.肿瘤临床试验设计的创新。
Cancer Treat Rev. 2019 Mar;74:15-20. doi: 10.1016/j.ctrv.2019.01.001. Epub 2019 Jan 4.
8
Adaptive designs in clinical trials: from scientific advice to marketing authorisation to the European Medicine Agency.临床试验中的适应性设计:从向欧洲药品管理局寻求科学建议到获得上市许可
Trials. 2018 Nov 20;19(1):642. doi: 10.1186/s13063-018-3012-x.
9
Socio-ecological dynamics and challenges to the governance of Neglected Tropical Disease control.被忽视热带病防治治理中的社会生态动态与挑战
Infect Dis Poverty. 2017 Feb 6;6(1):35. doi: 10.1186/s40249-016-0235-5.
10
An economic evaluation of "Health for All".“人人享有健康”的经济评估。
Health Policy Plan. 1986 Mar;1(1):37-47. doi: 10.1093/heapol/1.1.37.

引用本文的文献

1
Adaptive clinical trials in surgery: A scoping review of methodological and reporting quality.手术中的适应性临床试验:方法学和报告质量的范围综述。
PLoS One. 2024 May 28;19(5):e0299494. doi: 10.1371/journal.pone.0299494. eCollection 2024.
2
Effectiveness and safety of reactive focal mass drug administration (rfMDA) using dihydroartemisinin-piperaquine to reduce malaria transmission in the very low-endemic setting of Eswatini: a pragmatic cluster randomised controlled trial.采用双氢青蒿素-哌喹的反应性焦点群体药物管理(rfMDA)降低斯威士兰极低流行地区疟疾传播的效果和安全性:一项实用的整群随机对照试验。
BMJ Glob Health. 2021 Jun;6(6). doi: 10.1136/bmjgh-2021-005021.
3

本文引用的文献

1
Adaptive clinical trial design: has its time come?适应性临床试验设计:时机已到?
J Natl Cancer Inst. 2010 Aug 18;102(16):1217-8. doi: 10.1093/jnci/djq319. Epub 2010 Aug 6.
2
Clinical research in resource-limited settings: enhancing research capacity and working together to make trials less complicated.资源有限环境下的临床研究:提高研究能力并共同努力使试验更简便。
PLoS Negl Trop Dis. 2010 Jun 29;4(6):e619. doi: 10.1371/journal.pntd.0000619.
3
Research capacity strengthening in African countries.非洲国家研究能力的加强。
A Framework for Methodological Choice and Evidence Assessment for Studies Using External Comparators from Real-World Data.
基于真实世界数据的外部对照研究方法选择和证据评估框架。
Drug Saf. 2020 Jul;43(7):623-633. doi: 10.1007/s40264-020-00944-1.
4
Analysis of integrated clinical trial protocols in early phases of medicinal product development.药品研发早期阶段综合临床试验方案分析
Eur J Clin Pharmacol. 2017 Dec;73(12):1565-1577. doi: 10.1007/s00228-017-2335-y. Epub 2017 Sep 18.
5
Improving vaccine trials in infectious disease emergencies.改善传染病紧急情况下的疫苗试验。
Science. 2017 Jul 14;357(6347):153-156. doi: 10.1126/science.aam8334.
6
Clinical Trial Adaptation by Matching Evidence in Complementary Patient Sub-groups of Auxiliary Blinding Questionnaire Responses.通过匹配辅助盲态问卷回复中互补患者亚组的证据进行临床试验适应性调整。
PLoS One. 2015 Jul 10;10(7):e0131524. doi: 10.1371/journal.pone.0131524. eCollection 2015.
7
Two-stage activity-safety study of daily rifapentine during intensive phase treatment of pulmonary tuberculosis.肺结核强化期每日服用利福喷汀的两阶段活性-安全性研究
Int J Tuberc Lung Dis. 2015 Jul;19(7):780-6. doi: 10.5588/ijtld.14.0868.
8
The next generation of sepsis clinical trial designs: what is next after the demise of recombinant human activated protein C?*.下一代脓毒症临床试验设计:重组人活化蛋白 C 失败后,下一步是什么?*
Crit Care Med. 2014 Jul;42(7):1714-21. doi: 10.1097/CCM.0000000000000325.
9
Impact, challenges, and future projections of vaccine trials in Africa.非洲疫苗试验的影响、挑战和未来预测。
Am J Trop Med Hyg. 2013 Mar;88(3):414-9. doi: 10.4269/ajtmh.12-0576.
10
Trial designs for vaccines adapt to the times.
Nat Med. 2012 Mar 6;18(3):327. doi: 10.1038/nm0312-327.
Lancet. 2010 May 29;375(9729):1874. doi: 10.1016/S0140-6736(10)60874-4.
4
African networks launch to boost clinical trial capacity.非洲建立网络以提高临床试验能力。
Nat Med. 2010 Jan;16(1):8. doi: 10.1038/nm0110-8a.
5
Scarcity and inequity of mental health research resources in low-and-middle income countries: a global survey.中低收入国家精神卫生研究资源的稀缺与不平等:一项全球调查。
Health Policy. 2010 Mar;94(3):211-20. doi: 10.1016/j.healthpol.2009.09.009. Epub 2009 Oct 28.
6
Adaptive designs for randomized trials in public health.公共卫生随机试验的适应性设计
Annu Rev Public Health. 2009;30:1-25. doi: 10.1146/annurev.publhealth.031308.100223.
7
Optimizing trial design: sequential, adaptive, and enrichment strategies.优化试验设计:序贯、适应性和富集策略。
Circulation. 2009 Feb 3;119(4):597-605. doi: 10.1161/CIRCULATIONAHA.108.809707.
8
Adaptive trial design: a general methodology for censored time to event data.自适应试验设计:一种针对删失时间事件数据的通用方法。
Contemp Clin Trials. 2009 Mar;30(2):171-7. doi: 10.1016/j.cct.2008.12.002. Epub 2008 Dec 16.
9
A regulatory view of adaptive trial design.适应性试验设计的监管视角。
J Formos Med Assoc. 2008 Dec;107(12 Suppl):3-8. doi: 10.1016/s0929-6646(09)60002-4.
10
Data safety and monitoring boards for African clinical trials.非洲临床试验的数据安全与监测委员会。
Trans R Soc Trop Med Hyg. 2008 Dec;102(12):1189-94. doi: 10.1016/j.trstmh.2008.06.009. Epub 2008 Jul 21.